Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>Products>This Product


Product Description

BASi (Bioanalytical Systems, Inc.) established in 1974 has headquarters in West Lafayette, Indiana. It provides contract research services and niche instrumentation, serving the life sciences industries, primarily in drug research and development. BASi was founded by a Purdue University chemistry professor and a group of his doctoral level students. Utilizing their abilities in electrochemistry they developed a line of products to detect trace chemicals in complex matrices. In the late 80’s, BASi entered the services business utilizing liquid chromatography and mass spectroscopy to provide analytical services to clients in their drug discovery efforts.

CRO Services

Bioanalytical Services (including GLP)

•    Discovery, non-clinical and clinical bioanalytical support
•    Large and small molecule capability
•    Biomarker assays
•    High capacity, fast turnaround sample analysis (Phase 1 support)
•    FIM and Phase I support
•    Automated sample analysis
•    Cutting edge technology: LDTD source and Dried Blood Spot analysis
•    All systems Part 11 compliant
•    PK kit manufacturing

Non-clinical/GLP Toxicology Services

•    IND enabling studies
•    Non-clinical animal studies
•    Pathology service
•    Rodents, rabbits, dogs, swine, monkeys and others
•    All dose routes except inhalation
•    In-house dose preparation and analytical support

Discovery Research Services

•    Research/Discovery experiments: efficacy, target validation, new compound screening
•    PK/TK, optionally utilizing BASi’s proprietary Culex® system
•    Automated simultaneous dosing and sampling from conscious freely-moving animals (rodents, dogs, and monkeys)
•    Real time data from stress free animals reduces the number of animals used
•    Samples: blood, bile, urine and feces
•    Automates in-vivo microdialysis sampling from blood and tissues
•    Lead optimization allows real time in-vivo ADME experiments

Pharmaceutical Analysis and Stability Program Management (including GMP and GLP)

•    Formulation through post-market sample analysis
•    Method development, validation, revalidation, transfer
•    Stability support, lot release and comparator testing
•    Potency, purity, dissolution, water, physical testing
•    Stability storage
•    Medical device testing
•    In vitro bioequivalence analysis
Product BASi
Company BASi
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Purdue Research Park 2701 Kent Avenue West Lafayette, IN, 47906-1382 United States

Tel: +1-765-463-4527
Fax: +1-765-497-1102

Scientific News
Salford Lung Study - The First Real World Clinical Trial
In this podcast, we learn about the Salford Lung Study and its potential to revolutionize the way we assess new drugs and treatments around the world.
Editing Gene Mutations in Anemia
Researchers successfully use a new gene editing strategy to correct mutations that cause a form of anemia.
Nanomedicine Aims to Improve HIV Drug Therapies
New research aims to improve the administration and availability of drug therapies to HIV patients using nanotechnology.
Observing Direct Inheritance of Gene-Silencing RNA
Research has allowed for the observation of double-stranded RNA molecule being passed from parent to offspring in roundworms.
Fighting Cancer with Immune Response
New treatment elicits two-pronged immune response that destroys tumors in mice.
First Entirely 3D-printed Organ-on-a-Chip with Integrated Sensors
New approach to manufacturing may allow researchers to rapidly design organs-on-chips that match the properties of a specific disease or individual patient's cells.
Nanoparticles Offer Promising Platform for Flavivirus Treatment
New nanoparticle effectively vaccinated mice against one dengue strain and could be created to target all four.
Study Finds Key Regulator in Pulmonary Fibrosis
Researchers identify an enzyme that could open the way to therpies for chronic fatal lung disease.
Signaling Pathway Could Be Key to Improved Osteoporosis Treatment
Inhibition of SIK2 enzyme both stimulates bone formation and reduces bone breakdown in animal model.
Ovarian Cancer Insight
Study showed tumours release cytokines to attract macrophages, which secrete growth factors that in turn promote tumour growth.


SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,200+ scientific videos